Kazia Therapeutics Ltd
KZIA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001075880
No open-market purchases or sales by Kazia Therapeutics Ltd insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $50.7M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Kazia Therapeutics Ltd as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +12 vs. Q1 2026
- Shares held
- 3.64M
- +1.89M (+107.5%) vs. Q1 2026
- Total value
- $50.7M
- +$37.7M (+288.8%) vs. Q1 2026
- New holders
- 17
- 10 more added
- Sold out
- 5
- 4 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KZIA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $50.7M |
| Q1 2026 | 23 | $13.0M |
| Q4 2025 | 22 | $17.1M |
| Q3 2025 | 11 | $1.14M |
| Q2 2025 | 10 | $902.9K |
| Q1 2025 | 10 | $120.9K |
| Q4 2024 | 11 | $569.1K |
| Q3 2024 | 18 | $938.3K |
| Q2 2024 | 11 | $89.5K |
| Q1 2024 | 11 | $238.1K |
| Q4 2023 | 18 | $2.24M |
| Q3 2023 | 10 | $235.9K |
| Q2 2023 | 9 | $327.6K |
| Q1 2023 | 8 | $279.4K |
| Q4 2022 | 10 | $262.0K |
| Q3 2022 | 9 | $527.0K |
| Q2 2022 | 12 | $1.24M |
| Q1 2022 | 12 | $2.90M |
| Q4 2021 | 12 | $4.44M |
| Q3 2021 | 18 | $5.03M |
| Q2 2021 | 15 | $4.35M |
| Q1 2021 | 14 | $4.60M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Kazia Therapeutics Ltd; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Boxer Capital Management, LLC | 560,000 | $7.88M | 0.59% | +560,000 | New |
| Flputnam Investment Management Co | 414,958 | $5.84M | 0.07% | +272,489+191.3% | Added |
| Bleichroeder LP | 400,000 | $5.63M | 1.01% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 396,201 | $5.58M | 0.91% | +396,201 | New |
| Dauntless Investment Group, LLC | 354,208 | $4.99M | 8.65% | +274,376+343.7% | Added |
| Stonepine Capital Management, LLC | 345,179 | $4.86M | 3.70% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 200,300 | $2.30M | 0.00% | +300+0.2% | Added |
| Ensign Peak Advisors, Inc | 110,778 | $1.56M | 0.00% | +110,778 | New |
| Millennium Management LLC | 101,376 | $1.43M | 0.00% | +101,376 | New |
| UBS Group AG | 81,090 | $1.14M | 0.00% | +67,156+482.0% | Added |
| J. Goldman & Co LP | 68,491 | $964.4K | 0.03% | +68,491 | New |
| ADAR1 Capital Management, LLC | 61,550 | $866.6K | 0.04% | +61,550 | New |
| Jane Street Group, LLC | 57,140 | $804.5K | 0.00% | +57,140 | New |
| Barclays PLC | 56,999 | $802.5K | 0.00% | +33,000+137.5% | Added |
| Susquehanna International Group, LLP | 50,616 | $712.7K | 0.00% | +50,616 | New |
| Cooperman Leon G | 50,000 | $704.0K | 0.02% | +50,000 | New |
| Westside Investment Management, Inc. | 47,585 | $670.0K | 0.09% | −2,840−5.6% | Reduced |
| Morgan Stanley | 46,606 | $656.2K | 0.00% | +45,606+4,560.6% | Added |
| Marshall Wace, LLP | 44,231 | $622.8K | 0.00% | +44,231 | New |
| XTX Topco Ltd | 31,186 | $439.1K | 0.01% | +31,186 | New |
| BNP Paribas Arbitrage, SA | 30,090 | $423.7K | 0.00% | +29,009+2,683.5% | Added |
| Citadel Advisors LLC | 28,509 | $401.4K | 0.00% | +28,509 | New |
| Raymond James Financial Inc | 22,599 | $318.2K | 0.00% | +6,850+43.5% | Added |
| Sequoia Financial Advisors, LLC | 20,003 | $281.6K | 0.00% | −39,997−66.7% | Reduced |
| Engineers Gate Manager LP | 14,975 | $210.8K | 0.00% | +14,975 | New |
| Laird Norton Trust Company, LLC | 12,900 | $181.6K | 0.00% | +500+4.0% | Added |
| United Bank | 12,851 | $180.9K | 0.02% | +12,851 | New |
| Rockefeller Capital Management L.P. | 12,700 | $178.8K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2,863 | $41.4K | 0.00% | +2,863 | New |
| GAMMA Investing LLC | 1,926 | $27.1K | 0.00% | +358+22.8% | Added |
| Rhumbline Advisers | 1,296 | $18.2K | 0.00% | −106−7.6% | Reduced |
| SRS Capital Advisors, Inc. | 87 | $1.23K | 0.00% | +87 | New |
| Caitong International Asset Management Co., Ltd | 24 | $338 | 0.00% | +24 | New |
| Advisor Group Holdings, Inc. | 10 | $140 | 0.00% | −8,734−99.9% | Reduced |
| Allworth Financial LP | 1 | $15 | 0.00% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −193,114−100.0% | Sold out |
| Velan Capital Investment Management LP | 0 | $0 | 0.00% | −135,315−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −34,340−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −10,608−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |